meloxistad 7,5 mg tabletta
stada arzneimittel ag - meloxikám -
meloxistad 15 mg tabletta
stada arzneimittel ag - meloxikám -
paclitaxel stada 6 mg/ml koncentrátum oldatos infúzióhoz
stada arzneimittel ag - paclitaxel -
adempas
bayer ag - riociguat - magas vérnyomás, pulmonalis - a magas vérnyomáscsökkentők a pulmonalis artériás hipertónia számára - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. hatékonyságát igazolta, hogy a pah lakosság, beleértve a etiológiájú, idiopátiás, vagy örökölhető pah, vagy pah kapcsolódó kötőszöveti betegség. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.
gliclazide stada 60 mg módosított hatóanyagleadású tabletta
stada arzneimittel ag - gliklazid -
migratriptan 50 mg tabletta
stada arzneimittel ag - sumatriptan -
migratriptan 100 mg tabletta
stada arzneimittel ag - sumatriptan -
priligy 30 mg filmtabletta
berlin-chemie ag menarini group - dapoxetine -
priligy 60 mg filmtabletta
berlin-chemie ag menarini group - dapoxetine -
pylclari
curium pet france - piflufolastat (18f) - prosztatikus daganatok - diagnosztikai radiofarmakonok - ez a gyógyszer csak diagnosztikai célra használható. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).